Viviane Tabar is a neurosurgeon scientist whose clinical practice is focused on brain and skull base tumors. Her lab work is centered on the study of human pluripotent stem cells as cancer models and for the development of regenerative therapies for CNS disease. She has co-led a consortium for the development of human embryonic stem cell-derived dopamine neurons as cell therapy for Parkinson’s disease. This work has culminated in a clinical trial currently open at her institution and sponsored by BlueRock Therapuetics. The Tabar lab has pioneered the use of human pluripotent stem cells for brain tumor modeling, with a focus on histone mutant gliomas. Dr Tabar is a member of the National Academy of Medicine and is the current Chair of the department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York. She is a scientific advisor and a co-founding Investigator for BlueRock therapeutics.
Viviane Tabar, MD
Founding Investigator, BlueRock Therapeutics
Chair of Neurosurgery, Memorial Sloan Kettering